Cargando…
T50. SYMPTOMATIC AND FUNCTIONAL RESPONSE TO BREXPIP RAZOLE TREATMENT IN PATIENTS WITH ACUTE SCHIZOPHRENIA BY AGE
BACKGROUND: Atypical antipsychotics are the mainstay of treatment for schizophrenia, and have a meaningful effect on positive symptoms and agitation/aggression. More recently, treatment goals have shifted to target functioning; a cycle of deterioration often occurs in early schizophrenia in which re...
Autores principales: | Weiss, Catherine, MacKenzie, Erin, Therrien, Francois, Zhang, Peter, Meehan, Stine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887270/ http://dx.doi.org/10.1093/schbul/sby016.326 |
Ejemplares similares
-
Exploring life engagement from the perspective of patients with major depressive disorder: a study using patient interviews
por: Therrien, François, et al.
Publicado: (2022) -
O7.5. LONG-TERM SAFETY AND TOLERABILITY OF BREXPIPRAZOLE IN PATIENTS WITH SCHIZOPHRENIA
por: Hakala, Mika, et al.
Publicado: (2018) -
F56. IMPACT OF SIDE EFFECTS DUE TO SECOND-GENERATION ANTIPSYCHOTICS ON THE FUNCTIONING OF PATIENTS WITH SCHIZOPHRENIA: AN OBSERVATIONAL, PATIENT CENTERED, WEB SURVEY
por: Tandon, Rajiv, et al.
Publicado: (2018) -
Daily Stressors and Physiological Reactivity: The Role of Perceived Stress, Stress Reactivity, Neuroticism, and Age
por: Hughes, MacKenzie, et al.
Publicado: (2020) -
Information Seeking During the Pandemic: The Role of Age, Agency, and Fake News Concerns
por: Pearman, Ann, et al.
Publicado: (2021)